Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Medical Virology 2017

About Conference

ConferenceSeries Ltd takes immense pleasure & feels honoured in inviting the contributors across the globe to International conference and Expo on Medical virology and Infectious Diseases to be held during September 18-19, 2017 in Houston, Texas, USA , on the theme " Current concepts and trends in the field of medical virology”.

ConferenceSeries Ltd invites participants from all leading universities, research institutions, Virologist, Scientists, Research Scholars, Industrial professionals, Technologist and Student Delegates from Virology and Healthcare sectors to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the recent advancements and technologies being used and developed for the research on viruses.

Summary

Medical Virology 2017 welcomes attendees, presenters, and exhibitors from all over the world to Houston, TexasUSA. We are delighted to invite you all to attend and register for the “Medical Virology” which is going to be held during September 18-19, 2017 in Houston, TexasUSA. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at International conference on Medical virology Summit and Expo, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Virology Congress 2017 organizing committee look forward to meet you at Houston, Texas, USA .

Importance & Scope:

Medical Virology-2017 will give a new look to study of viruses. Medical Virology is often considered an interdisciplinary part of Virology or of Pathology. Viruses and viral diseases have been at the centres of science, agriculture, and medicine for millennia and some of our greatest challenges and triumphs have involved virology. Medical Virology-2017 addresses and discuss on the recent advancements and technologies being used and developed for the research on viruses. Our Medical Virology conference is bringing experts from the field of Virology for discussion of the latest advances and ideas and to stimulate interdisciplinary interactions. Conference like ours will help to speed up of the development of effective therapies for diseases of infectious viruses.

Why Texas, USA?

Houston is the most populous city in Texas and the fourth most populous city in the United States. With a census-estimated 2014 population of 2.239 million people within a land area of 599.6 square miles (1,553 km2), it also is the largest city in the Southern United States, as well as the seat of Harris County. Houston’s economy has a broad industrial base in energy, manufacturing, aeronautics, and transportation. It is also leading in health care sectors and building oilfield equipment. The Port of Houston ranks first in the United States in international waterborne tonnage handled and second in total cargo tonnage handled. Nicknamed the Space City, Houston is a global city, with strengths in business, international trade, entertainment, culture, media, fashion, science, sports, technology, education, medicine and research. The city has a population from various ethnic and religious backgrounds and a large and growing international community. Houston is considered to be the most diverse city in Texas and the United States. It is home to many cultural institutions and exhibits, which attract more than 7 million visitors a year to the Museum District. Houston has an active visual and performing arts scene in the Theatre District and offers year-round resident companies in all major performing arts.

Conference Highlights:

  • Internal medicine
  • Virology Contribution to Medicine
  • Antiviral Research
  • Model Systems of Virology
  • Viral Nanoparticles
  • Human Viruses in Water
  • Therapeutic Approaches and Targets for Viral Infections
  • Viral Like Particles (VLPs)
  • Biotechnology
  • Viruses Cancer
  • Immunology
  • Pediatric virology
  • Infectious Diseases of Viruses
  • Human Virology
  • Clinical Virology
  • Trends In Virology
  • Diagnostics of Viruses
  • Advances In Virology
  • Control of Viruses
  • Bioweapons
  • Bacteriophage
  • Agriculture & Plant Virology
  • Pathgology

Top Universities in USA:

  • Rice University
  • Texas A&M University
  • LeTourneau University
  • University of Texas at Dallas
  • Southwestern University
  • Texas Tech University

Top Societies and Associations in USA

  • Infectious Diseases  Society of America
  • American Society for Virology
  • Pan American Society for Clinical Virology
  • International Society for Antiviral Research
  • American Society for Microbiology USA       

Top Societies and Association around the World

  • Centre for Emerging Viral Infections Research
  • Hunter Medical Research Institute
  • Centre for Global Research and Intervention in Infectious Diseases
  • Infectious and Immunologic Diseases Research Centre
  • Global virus network
  • HIV Medicine Association
  • International AIDS Society
  • Canadian Society for International Health 
  • Microbiology Society
  • International Union of Microbiological Societies
  • Federation of European Microbiological Societies European Union
  • The Royal Society of Pathologists UK
  • Hellenic Society of Virology
  • Danish Society for Virology
  • International Society for Antiviral Research
  • National Foundation for Infectious Diseases
  • Society for General Microbiology
  • Society for Industrial Microbiology
  • Centre for Emerging Viral Infections Research
  • Hunter Medical Research Institute
  • Centre for Global Research and Intervention in Infectious Diseases
  • Infectious and Immunologic Diseases Research Centre
  • Global virus network
  • HIV Medicine Association
  • International AIDS Society
  • Canadian Society for International Health

Target Audience:

  • Virology Students, Scientists
  • Virology Researchers
  • Virology Faculty
  • Medical Colleges
  • Virology Associations and Societies
  • Research Labs
  • Manufacturing Medical Devices Companies

A Unique Opportunity for Collaborating with Funding agencies and Research Centres at this International event.

 

 

Market Analysis

Summary:

Medical Virology-2017 is the premier event that brings together a unique and International mix of experts, researchers and decision makers from both academia and industry across the globe to exchange their knowledge, experience and research innovations. The scope of Medical Virology-2017 is to bring the advancements in the field of Virology and viruses which are of contributing significant global burden of infectious diseases. Medical Virology focuses in particular on the most current research related to the laboratory diagnosis of human and animal infections and the role of the laboratory in both the management of infectious diseases and the elucidation of the epidemiology of infections, the latest developments in Medical Virology and Techniques in Virology, providing the current state of knowledge in the field, as well as balanced, thought-provoking perspectives on controversial issues.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations, video presentations and various programs for participants from all over the world. We invite you to join us at the Medical Virology-2017, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Medical Virology-2017 organizing committee look forward to meet you in Houston, Texas, USA .

Importance and Scope:

Medical Virology-2017 will be the best platform for all the Virologist, Scientists, Research scholars, Students, Technologist who are working in this field to exchange their knowledge related to Medical Virology and Infectious Diseases. This International event is an effort to find an alternative for different new technique against diseases caused by infectious viruses.

Why to attend?

In today's economic climate your business decisions are as crucial as ever. International Conference and Expo on Medical virology and Infectious Disesaes allow you to maximize your time and marketing dollars while receiving immediate feedback on your new products and services. International Conference on Medical virology Summit and Expo is organizing an outstanding Scientific Exhibition/Program and anticipates the world's leading specialists involved in Medical Virology and Techniques in Virology. Your organization will benefit with excellent exposure to the leaders in Medical virology Summit and Expo. Medical Virology-2017 is an exciting opportunity to showcase the new technology, the new products of your company, and/or the service your Industry may offer to a broad international audience.

Why Texas, USA?

Houston is the most populous city in Texas and the fourth most populous city in the United States. With a census-estimated 2014 population of 2.239 million people within a land area of 599.6 square miles (1,553 km2), it also is the largest city in the Southern United States, as well as the seat of Harris County. Houston’s economy has a broad industrial base in energy, manufacturing, aeronautics, and transportation. It is also leading in health care sectors and building oilfield equipment. The Port of Houston ranks first in the United States in international waterborne tonnage handled and second in total cargo tonnage handled. Nicknamed the Space City, Houston is a global city, with strengths in business, international trade, entertainment, culture, media, fashion, science, sports, technology, education, medicine and research. The city has a population from various ethnic and religious backgrounds and a large and growing international community. Houston is considered to be the most diverse city in Texas and the United States. It is home to many cultural institutions and exhibits, which attract more than 7 million visitors a year to the Museum District. Houston has an active visual and performing arts scene in the Theatre District and offers year-round resident companies in all major performing arts.

Top Societies and Association around the World

  • Centre for Emerging Viral Infections Research
  • Hunter Medical Research Institute
  • Centre for Global Research and Intervention in Infectious Diseases
  • Infectious and Immunologic Diseases Research Centre
  • Global virus network
  • HIV Medicine Association
  • International AIDS Society
  • Canadian Society for International Health 
  • Microbiology Society
  • International Union of Microbiological Societies
  • American Society for Microbiology USA
  • Federation of European Microbiological Societies European Union
  • The Royal Society of Pathologists UK
  • Hellenic Society of Virology
  • Danish Society for Virology
  • International Society for Antiviral Research
  • National Foundation for Infectious Diseases
  • Society for General Microbiology
  • Society for Industrial Microbiology
  • Centre for Emerging Viral Infections Research
  • Hunter Medical Research Institute
  • Centre for Global Research and Intervention in Infectious Diseases
  • Infectious and Immunologic Diseases Research Centre
  • Global virus network
  • HIV Medicine Association
  • International AIDS Society
  • Canadian Society for International Health

Target Audience:

  • Virology Students, Scientists
  • Virology Researchers
  • Virology Faculty
  • Medical Colleges
  • Virology Associations and Societies
  • Research Labs
  • Manufacturing Medical Devices Companies

A Unique Opportunity for Advertisers and Sponsors at this International event.

Market Analysis Report

 The Comprehensive virology market is anticipated to evolve in next 10 years since prevalence of pathogenic diseases, growth in discovery of mutating and adapting viruses, and the progressing need for emerging techniques in Medical Virology which is interdisciplinary of Virology/microbiology and pathology. During 2015-2016, the virology industry has been profoundly influenced by contagious viruses such as Ebola, MERS, hepatitis C viruses & zika viruses. By 2017, is dominating the research, with better prospects in the near future, since few important patents are approaching expiry, including Tamiflu, Sustiva, Tenofovir, Combivir, Relenza, and Telbivudine. With the expiry of these blockbuster drugs, the market is estimated to encounter a dynamic competitive landscape. The generic competition in the virology market will be in this high pace from 2017 onward.  The Americas commanded the largest share and Europe is projected to maintain the position as the second largest market globally. During the forecast periods, America and Europe is anticipated to record the highest CAGR, governed by enhanced healthcare infrastructure, access to diagnostics, and enhanced affordability of diagnostic tests for viral diseases.

Cancer Immunology & Oncolytic Virology  market (2011-2018)

·         The global cancer Cancer Immunology & Oncolytic Virology  market reached nearly $29.00 billion in 2011. This market is expected to grow to $67.90 billion in 2018 with a compound annual growth rate (CAGR) of 14.7%.

·         The USA market for Cancer Immunology & Oncolytic Virology  market reached nearly $14.00 billion in 2011. It is further projected to grow to nearly $30.7 billion in 2018 with a CAGR of 15.0% over the five-year period, 2013 to 2018.

·         The European market for Cancer Immunology & Oncolytic Virology  market reached nearly $7.9 billion in 2011. It is further projected to grow to nearly $14.4 billion in 2018 with a CAGR of 10.5%.

Scope of Cancer Immunology & Oncolytic Virology market 

Cancer Immunology & Oncolytic Virology  market  provides an overview of the current and potential global market for cancer immunotherapy and virology. It identifies the need for more effective drugs for treatment of infectious diseases caused by viruese. This report provides important trends in field, new developments and sales forecasts for Cancer Immunology & Oncolytic Virology from 2011 through 2018.  Issues and trends addressed in this report are based on information from industry sources, regulatory and healthcare policies, demographics and other factors that directly affect the cancer market. The report also addresses opportunities for future players.

There is an increasing need for new and innovative drugs. This young industry is experiencing tremendous growth. This field is still in its infancy, showing immense promise for the clinical management of cancer.

Sessions/Tracks

Track 1: Virology Contribution to Medicine

Viral Molecular medicine is an immense field, which enables to develop molecular interventions to precise molecular and genetic flaw of viral infection and or disease as the result of physical, chemical, medical and bio-analytical techniques are being used to characterise molecular structures and mechanisms. This Viral molecular medicine field of study enables not only emphasizes cellular and molecular biochemistry phenomena also gives a scope to interventions instead of previous conceptual and observations.

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 2: Advances in Virology

Context of the propagative research on infectious diseases of virus prompting the utilization of progressive analytical techniques and methodologies to overcoming impediment challenges and risk to mankind by collaborating the translation and exchange of emerging ideas and advancements by blending with distinct research fields results. We have to focus to develop the field of medical virology which is interdisciplinary of applied virology by promoting progressive technologies and convergence areas of research that have not been utilised previously.

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 3: Trends in Virology

Viruses are contributing significant global burden of infectious diseases. Many of the infections are causing mild effects of diseases, but, when the individuals are mal-nourished, negotiable immunity at the late age and the very young age, viruses may cause severe infectious diseases in such susceptible. The development of potential assays for the diagnosis of these diseases as result of current observations in the viral aetiology of many infectious diseases, and considerable progress in our insight of the history and the steps of the viral life cycle, pathogenesis and chemotherapy of infectious diseases.

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 4: Diagnostics of Viruses

Diagnostic techniques in virology are progressing beyond the diagnostics into the research and laboratory. Various animal infectious disease systems are using as models for human infectious diseases. Using several distinct types of molecular methodologies, such as cloning and inserting and deleting genetic information, viruses are being engineered in several distinct approaches to improve mankind and animal health. Improved vaccines, viruses engineered to carry genetic information for use in gene therapy, as well as for use in cancer treatment as a result of such approaches only. Medical Virology which is interdisciplinary of Virology/Microbiology is a continually expanding and progressive field with much left to discover.

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 5: Control of Viruses

Contemporary management of infectious viruses such as HIV virus, Ebola virus, Human parainfluenza viruses (HPIV), Hepatitis Virus, Flu are  catering a new way for the integration of molecular techniques into management of chronic viral infections. Such progresses are not only emphasizing the use of diagnostic virology also amendment the field of virology techniques.  

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 6: Therapeutic Approaches and Targets for Viral Infections

To fortify humoral and cellular immune responses to protect against viral infections by injecting with genetically reprogrammed genetic material is DNA immunization is one of the efficient methods. Viral vaccines holds either constricted or inactivated viruses. Inactive viral vaccines contain a virus, that which doesn’t have ability to replicate and in order for it to bring about a response it contains more antigen than live immunization. In recent days many of approaches are clinically documented efficacious treatment, which are may considerably reduce the patient’s unhealthy conditions and the need for traditional, symptom-relieving medication.

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 7: Viral Immunology

Viral Immunology is delivering the cutting-edge focus on translational research on unusual, emerging, and under-studied infectious viruses, with exceptional focus on analysing mutual relationships among external viruses and internal immunity, including the role of innate immunity and adaptive immunity in the establishment, containment and/or breakthrough of infectious diseases of viruses, which is resulting as a cancer, includes vaccine and adjuvants strategies.   

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 8:  Antiviral Research

Virus is obligatory and intracellular parasite, since replication of virus requires the pathways and functions of the host cell. As a consequence, it is laborious to characterize specific functions of infectious viruses as good enough targets for anti-infective therapy. Nevertheless, since 50 years significant progress has been fashioned towards the development of effective and specific antivirals. In Particular, HIV, Hepatitis B & Hepatitis C viruses, are of causing chronic infections and affecting millions of mankind world-wide, are extensive spotlight of research in antivirals. Initially, antivirals were mainly directed against virus-specific enzymes; currently, drugs are inhibiting the steps of infectious viral entry or release has been developed. Enlightened paths towards drug development have become progressive successful as a result of characterization structure and function of viral proteins and molecular mechanisms of virus-host interactions. Innovative strategies are exploring in essential research or preclinical studies including paths to target host factors those are essential for replication of infectious virus, exploitation of the innate immune response system along with utilisation of gene silencing strategies targeting at meddlesome with the gene expression of infectious virus. Nowadays various virostatics targeting various viral replication steps are approved to treat critical infectious viral diseases. Even though, the employment of such drugs is finite by the swift development of antiviral resistance, which results a substantial complications of contemporary antiviral therapy.

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 9: Viruses Cancer

As per the World Health Organization (WHO) records, nearly 20% of the cancers in the world as a result of chronic infections, in developing countries roughly 15% of human cancers  are characterised and with higher incidence of viruses only. Since past century relation between viruses and cancer is one of the crucial discoveries in cancer research.   

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |           

Track 10: Human Virology

Human Virology deals with diseases due to the infectious viruses in humans, viruses those which are infecting humans can target essentially in every tissue of the body which results further deadly diseases. Characterising and understanding infectious disease processes must be refined for all viruses separately. An account of the analysis of infectious virus role in human disease, thus have to be significant advances to understand such agents and breakthrough in prevention and treatment of infectious diseases. Nevertheless, infectious diseases caused by viruses endure to be a macro constituent of the morbidity and premature mortality burden for mankind. Due to the emergence of viruses is constant threat, such as HIV, Hepatitis, Ebola, Zika virus, Avian influenza, Flu (influenza), HPV, Herpes & SARS and etc. which are of our most common experience of infectious viruses cause of viral pneumonia, Herpes, Human papillomavirus (HPV), AIDs, Infectious mononucleosis, mumps, measles, rubella, Shingles, Viral gastroenteritis (stomach flu), Viral meningitis, Hepatitis and etc.,

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 11: Viral Infection Transmission

Viral Infection Transmission is the process by where viruses will spread between the hosts, including either members of the similar hosts or spread to different species in case of viruses can cross beyond the species barriers, which results in emerging new diseases are threat to health of people.

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 12: Viral Nanoparticles

Around the world medical researchers and doctors are trying to cure cancer since some centuries and also been succeeded in some cases and helped millions of people to reprieve with treatment methods including surgery, radiation therapy, chemotherapy, hormone therapy, and biological therapy, even though nowadays treatment methods are of having so many side effects especially in cancer patients are fatigued, weak, nauseous hair loss and irritated skin, and the drug efficiency is also very poor, so patients are badly needed toxic treatment in lot to receive benefits from these treatments. Viral nanoparticles are being revolutionized cancer treatment, not only as a safer, also more specific form of cancer treatment, which is emerging imaging tool.

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 13: Viral Like Particles (VLPs)

VLPs (Virus-like particles) are proteins structures that which are of mimic the confirmation and organisation of native viruses without viral genome with potential yielding, safer and economical vaccine candidates. GlaxoSmithKline's Engerix (Hepatitis B Virus) and Cervarix (Human Papilloma Virus), and Merck and Co., Inc.'s Recombivax HB (Hepatitis B Virus) and Gardasil (Human Papilloma Virus) are some of the examples which are of using VLP-based vaccines currently commercialized worldwide. Influenza virus, parvovirus, Norwalk and various chimeric VLPs are in clinical trials or undergoing preclinical evaluation and other VLP-based vaccine candidates are restricted to small-scale fundamental research. Even though successful VLP-based vaccine blockbusters are in market but still need of new-generation VLP-based technology for either therapeutic or prophylactic vaccination against prevalent and emergent diseases.

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 14: Viral Biotechnology

Viral Biotechnology interdisciplinary of Biotechnology is a scientific and research field having extensive scope, which is using research tools from biochemistry and molecular biology to characterise and solve problems such as infectious diseases being caused by viruses. Biotechnologists are being used to study the genetic material of viruses including other distinct microbial machinery to understand factors that are contributing to human diseases.  Emerging technologies can be used to develop diagnostic tests that enable sensitive and quick analysis and characterisation of the viral infectious diseases leads to develop dynamic treatments and methodologies.

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 15: Paediatric Infectious Diseases

Paediatric infectious disease is not an isolated discipline. Rather, the syndromes associated with viral infection are modified by the unique characteristics of infancy and childhood. Fortunately for the paediatrician, and certainly for children, viral infections in childhood are rarely fatal, and are almost never serious. Future efforts of the paediatrician and virologist should be directed toward increased foetal salvage as with rubella and the prevention of severe, viral lower respiratory tract disease.

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 16: Bioweapons

Viral Bioweapons are the living organisms accommodated with viruses those which will reproduce and replicates within their host victims. Those are often biological toxins with an objective to kill humans, animals or plants. Theses viral bioweapons also targets fisheries, water based vegetation, target plants to destroy crops and defoliate vegetation in agriculture. Main characteristics of a viral bioweapons can be characterised as high infectivity, high virulence, non-availability of vaccines and efficient delivery system, such as Ebola virus, Rift valley fever virus, Japanese encephalitis virus, Yellow fever virus. Bio-herbicides and Myco-herbicides are used as bioweapons. To treat wheat blast and rice blast disease, aerial spray tanks and cluster bombs are used as bioweapons. Viral Bioterrorism, that which involves the intentional release of biological agents such as viruses.

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 17: Bacteriophage

Since 50 years, most of the scientists, doctors and clinicians have been utilising earlier antibiotics to treat infectious diseases which are of causing by pathogenic bacteria. Even though, emergence of bacterial resistance to antibiotics following widespread clinical, veterinary, and animal or agricultural management being less effective for antibiotics. Recent reports are showing that scientists are facing the threat of superbugs, i.e. pathogenic bacteria resistant to most or all available antibiotics. Pharmaceutical companies being focused on the development of novel approaches for products derived from bacteriophage as antimicrobial agents.

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 18: Clinical Virology

Clinical Virology is interdisciplinary of virology/medical virology and healthcare science which characterise and resolve the safety and efficacy of medications, devices, diagnostic products and treatment regimens intended for mankind, which can be utilise for prevention, treatment & diagnose for alleviate the infectious viral diseases. When comparing with clinical practice, clinical research is distinct, which gives evidences of collected results to found therapeutic approaches for infectious viral diseases. The human immunodeficiency virus is a lentivirus causes acquired immunodeficiency syndrome. HIV/AIDS diagnosis is done by testing your blood or saliva for antibodies to the virus. HIV/AIDS clinical trials are research studies are progressing towards novel approaches towards prevent, detect, or treat HIV/AIDS. Through Clinical Trials can be possible to determine if new medical approaches to HIV/AIDS are safe and effective in people.

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 19: Human Viruses in Water

Waterborne enteric Viruses belongs to such as reovirus, rotavirus, poliovirus, coxsackievirus, echovirus, enterovirus, hepatitis A virus,  Norwalk virus, astrovirus, calicivirus, Snow Mountain agent, small round structured virus,  adenovirus strains 3, 7, 40, and 41 are threatening not only animal health also to mankind’s health. Extensive research has documented the risk of infectious viruses, are of host specific those are of cause wide range of diseases such as ocular and respiratory infections to gastroenteritis, hepatitis, myocarditis, and aseptic meningitis; in almost living beings from contact with contaminated water, current methods that which is bacterial indicator base of evaluation quality of water, are often ineffectual proxies for infectious viruses. RNA viruses are of causing gastroenteritis with diarrhoea and/or vomiting, fever. Rotavirus is causative agent for gastroenteritis. With progressive molecular analysis, infectious viruses from key host groups should be targeted directly by using either PCR amplification or hybridization with a high level of sensitivity and specificity. Analysis which provides information about multispecies to control and determine, based on loading and exposure of infectious virus to evaluate potential risks to animal health and could indicate the potential for the presence of other zoonotic infectious organisms. Need to be better understanding of prevalence and environmental distribution of nonhuman enteric viruses, emerging of advanced sensitive methods for specific analysis will facilitates the utilisation of microbes for library independent source tracking and assessment tools for water quality.

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

Track 20: Model Systems of Virology

To Identify, characterise, quantify, and predict the changes in host response that distinguish between pathogenic and attenuated viruses that lack key virulence factors of infectious, which results to identify unique, novel, and regular molecular signatures in the host response to wide variety of infectious viruses which represents therapeutic intervention of future targets for those which are causing such as  gastroenteritis leading to morbidity and mortality, diarrhoea-related deaths, necrotising enterocolitis (NEC) in neonates and seizures causing viruses by utilising multiple model systems such as   in vitro culture systems, primary cell culture, non-human primates and pigs, sheep, cattle, rabbits, hares, rabbit, cats, feline, mice and murine are as  whole animal models. Most of the viruses such as Calicivirus, Norovirus, Tulane virus, Sapovirus, Rabbit haemorrhagic disease virus (RHDV), Feline Calicivirus, Murine norovirus and etc., are using as model systems to study about basic mechanisms of pathogenesis of infectious disease, molecular mechanisms of genome translation and replication.

Relevant Conferences: : 8th World Congress on Virology November 28-30,  2016 San Antonio, USA | 11th World Congress on Virology November 13-15,2017 Atlanta, USA | 5th World Congress on Virology December 07-09, 2015 Atlanta, USA | 4th World Congress and Expo on Applied Microbiology September 19-21, 2016 Las Vegas, USA | Annual Meeting on Viral Outbreaks and Epidemiology October 16-18, 2017 Baltimore, USA |10th World Congress on Virology and Mycology May 11-12, 2017 Singapore | 7th Annual Congress on Clinical Microbiology August 28-30, 2017 Philadelphia, USA | Global Veterinary Microbiology Summit & Expo Oct 2-4, 2017 Las Vegas, USA | Association of Medical Microbiology and Infectious Disease Canada | European Society for Clinical Virology | Association of Medical School Microbiology and Immunology Chairs | Indian Association of Medical Microbiologists & American Society for Microbiology |

 

 

 

 

Past Conference Report

Euro Virology 2016

Past Conference Report

Euro Virology 2016

Sensing the raising importance of Viruses, Conferenceseries LLC hosted the “6th Euro Virology Congress and Expo” (Euro Virology 2016), during March 10-12, 2016 in Madrid, Spain with a theme “An Insight on Advances in Virology and Infectious Diseases”. Benevolent response and active participations were received from the Editorial Board Members of OMICS International Journals as well as from the Virologists, Microbiologists, Researchers, Doctors, Students and Leaders from the fields of Virology Research, who made this event inspiringly successful.

The Euro Virology 2016 Conference was carried out through various sessions with discussions on the following thought provoking and cerebrating scientific tracks:

Veterinary Virology

Drug discovery program

Recent Advances in Viral Therapy

Current Focus in Virology Research

Viral Evolution & General Virology

HIV & Other Emerging Viruses affecting Afro-Asian Continents

Viral hepatitis

Vaccines and Viral Vectors

Agriculture and plant virology

Clinical & Neuro Virology

Pediatric Viral Diseases

Therapeutic Approaches & Targets for Viral Infections

Tumor Virology and Immunology

Host Immune Defenses & Immunotherapy

The conference was initiated and embarked with an opening ceremony followed by workshop and a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The peerless people who promulgated the theme with their exquisite talks were;

Dr. Khaled Barakat, University of Alberta, Canada

Dr. Hiroshi Ohrui, Yokohama University of Pharmacy, Japan

Dr. Walter Doerfler, University of Erlangen-Nuernberg & Cologne University, Germany

Dr. Angelika Krumina, Riga Stradins University, Latvia

Dr. Kunihiro Kaihatsu, Osaka University, Japan

Conferenceseries LLC on behalf of Organizing Committee Members and Editorial Board Members congratulates the Best Poster Awardee for her outstanding contribution in the field of Virology and simultaneously encourage all the participants who tried to put their efforts in poster presentations and wish them success in their future research.

Best Poster Awardees

• Ana Godinho-Santos, University of Lisbon, Portugal; INSERM, France

Title: CIB1 and CIB2 are HIV-1 helper factors involved in envelope-mediated viral entry.

Conference Series LLC offers its heartfelt appreciation to Societies and Organizations such as Latvian Association of Infectologists and Hepatologists, also obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with Conference Series LLC in supporting and making the conference as never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Euro Virology 2016, Conferenceseries LLC is delighted to announce the next event. Mark your calendars for the upcoming extravaganza, “International Conference and Expo on Medical Virology” to be held during August 31-September 1, 2017 Philadelphia, USA.

 


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date (10 Plenary Forums 2 Days 1 Event)
September 18-19, 2017

Speaker Opportunity

Day 1 Day 2

Supported By

Journal of Antivirals & Antiretrovirals Virology & Mycology Journal of AIDS & Clinical Research Journal of Clinical & Cellular Immunology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators

exhibitor

Exhibitor